CVR number 43339036
Industry 46.4620 Wholesale of pharmaceutical goods

World Medico ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  0.0% 0.0% 0.0% 7.1% 29.8%  
Credit score (0-100)  0 0 0 33 1  
Credit rating  N/A N/A N/A BBB C  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 3,802 -104  
EBITDA  0.0 0.0 0.0 2,367 -3,222  
EBIT  0.0 0.0 0.0 2,367 -3,222  
Pre-tax profit (PTP)  0.0 0.0 0.0 2,006.8 -3,016.5  
Net earnings  0.0 0.0 0.0 1,561.6 -3,016.5  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 2,007 -3,017  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 1,762 -1,255  
Interest-bearing liabilities  0.0 0.0 0.0 59.4 2,053  
Balance sheet total (assets)  0.0 0.0 0.0 9,929 6,362  
Net Debt  0.0 0.0 0.0 -87.1 2,050  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 3,802 -104  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 4 10  
Employee growth %  0.0% 0.0% 0.0% 0.0% 150.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 9,929 6,362  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -35.9%  
Added value  0.0 0.0 0.0 2,366.9 -3,222.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 -1.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 62.3% 3,102.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 24.7% -31.3%  
ROI %  0.0% 0.0% 0.0% 134.4% -141.8%  
ROE %  0.0% 0.0% 0.0% 88.6% -74.3%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% 0.0% 17.7% -16.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -3.7% -63.6%  
Gearing %  0.0% 0.0% 0.0% 3.4% -163.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 1,485.5% 25.6%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 0.0 0.1 0.2  
Current Ratio  0.0 0.0 0.0 1.2 0.8  
Cash and cash equivalent  0.0 0.0 0.0 146.6 3.3  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 1,744.6 -1,285.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 592 -322  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 592 -322  
EBIT / employee  0 0 0 592 -322  
Net earnings / employee  0 0 0 390 -302